Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Phase III Trials
80%
Intensive Care
80%
Congestive Heart Failure
80%
Renin Angiotensin Aldosterone System
80%
Coronavirinae
80%
Infection
80%
Levosimendan
80%
Noncardiac Surgery
80%
Dipeptidyl Carboxypeptidase
57%
Angiotensin I
57%
angiotensin[1-7]
45%
Angiotensin II
45%
Personhood
40%
Aldosterone
34%
Liquid Chromatography-Mass Spectrometry
34%
Natriuretic Factor
32%
Placebo
32%
Tandem Mass Spectrometry
22%
Acute Respiratory Distress Syndrome
22%
Metabolite
22%
Intensive Care Unit
20%
Diseases
20%
Amino Terminal Sequence
16%
4 Chloro 3',6' Dimethyl 2,2' Iminodibenzoic Acid
16%
Primary Outcome
16%
Single Drug Dose
16%
Angiotensin II [3-8]
11%
Angiotensin III
11%
Renin
11%
Intensive Care Medicine
11%
SOFA Score
11%
Angiotensin
11%
Multivariate Logistic Regression Analysis
11%
Neuroscience
Levosimendan
80%
Coronavirinae
80%
Aldosterone
80%
Coronavirus
80%
Angiotensin
80%
Renin
80%
Blood Plasma
80%
Angiotensin I
57%
Dipeptidyl Carboxypeptidase
57%
angiotensin[1-7]
45%
Angiotensin II
45%
Liquid Chromatography-Mass Spectrometry
34%
Natriuretic Peptide
32%
Placebo
32%
Distress Syndrome
22%
Amino Terminal Sequence
16%
Angiotensin II [3-8]
11%
Angiotensin III
11%
Nursing and Health Professions
Intensive Care Unit
100%
Intensive Care
90%
Counseling
80%
Ethics
50%
Health Care Planning
26%
Health Care
26%
Patient Experience
20%
Sedation
20%
Diseases
20%
Critical Illness
10%
Posttraumatic Stress Disorder
10%
Nurse
10%
Psychologist
8%
Digitization
8%
Continuous Quality Improvement
8%
e-counseling
8%
